Latest fiscal year 2025 · computed deterministically from XBRL 10-K data · coverage 100%
In fiscal 2025, USANA HEALTH SCIENCES, INC. reported revenue of $925M, up 8.3% year over year. Operating margin was 4.0% and net margin 1.2%, on a free-cash-flow margin of 0.9% with capital expenditure at 1.5% of revenue. Every figure is computed directly from USNA's SEC XBRL 10-K filing — deterministic, with no estimates.
| Fiscal year | Revenue | Op margin | Net margin |
|---|---|---|---|
| FY2025 | $925M | 4.0% | 1.2% |
| FY2024 | $855M | 7.8% | 4.9% |
| FY2023 | $921M | 10.1% | 6.9% |
| FY2022 | $999M | 10.8% | 6.9% |
| FY2021 | $1.19B | 14.3% | 9.8% |
How does USNA compare against its actual peer set?
A CompsDesk subscription covers unlimited benchmark packs on any covered company: up to 19 metrics (6 core guaranteed) × up to 5 fiscal years × up to 12 chosen peers, percentile placement, the subject's figures cited to their SEC tag, form and period with every company identified by its CIK, PDF-ready HTML + CSV, generated on demand.
Related in the same sector: AAWH · ABBV · ABCL · ABT · ABUS · ACAD
Source: SEC EDGAR XBRL (10-K filings), latest filed values. "n/a" = not disclosed under mapped tags — never estimated. Informational benchmarking, not investment advice. © CompsDesk / Sam Arora.